NCT00806169View on ClinicalTrials.gov

Combined Triple Therapy in Diabetic Retinopathy (DRP)

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

November 30, 2008

Conditions
Macular EdemaDiabetic Retinopathy
Interventions
DRUG

triamcinolone and bevacizumab

Trial Locations (1)

60590

Department of Vitreoretinal Surgery, Frankfurt am Main

All Listed Sponsors
lead

Johann Wolfgang Goethe University Hospital

OTHER

NCT00806169 - Combined Triple Therapy in Diabetic Retinopathy (DRP) | Biotech Hunter | Biotech Hunter